The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Completed · Phase 3

Conditions studied: Macular Edema, Cystoid, Retinal Vein Occlusion

In brief

The SCORE Study will compare the effectiveness and safety of standard care to intravitreal injection(s) of triamcinolone for treating macular edema (swelling of the central part of the retina) associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).

Key facts

Study ID

NCT00105027

Run by

The Emmes Company, LLC

People needed

682

Starts

2004-10-01

Expected to finish

2009-02-01

Last updated by the study team

2018-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with macular edema (swelling of the central part of the retina) associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
• Individuals, 18 years of age or older, willing to provide consent may be eligible for the SCORE Study.
• Exclusion Criteria: refer to SCORE Study website at https://web.emmes.com/study/score/ for listing.

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.